NTRK2 has previously been implicated in several types of cancers including neuroblastoma, medulloblastoma, Wilm’s tumor and adenocarcinomas of the lung, prostate and pancreas as well as multiple myeloma [27–30]. Here, NTRK2 is linked to lung adenocarcinoma.